Search results
Spago Nanomedical Receives Declarations of Intent from the Largest Owner, Board and Management Team...
Morningstar· 2 days agoIn total, these declarations of intent are expected to...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 2 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG...
WKRN Nashville· 2 days agoGrey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation therapies to address the source of immune dysfunction ...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 2 days agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Bull Market Buys: 2 Growth Stocks to Own for the Long Run | The Motley Fool
The Motley Fool· 3 days agoThe stock market is roaring higher, with the Nasdaq and S&P 500 recently extending gains to reach...
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
The Motley Fool via AOL· 3 days agoAmtagvi is approved for advanced melanoma, the deadliest of skincancers -- and this represents the...
Under the Dome: A congressman’s diagnosis, a budget update and pushback on masks
Durham Herald-Sun via Yahoo News· 3 days ago“I think we’ve still got time to get things moving so that we can get finished by the end of June,”...
How Insitro’s big hires help it push AI drug discovery - San Francisco Business Times
The Business Journals· 2 days agoThe hires, including former Pfizer Inc. early cancer drug development chief S. Michael Rothenberg as...
Illness took away her voice. AI created a replica she carries in her phone
Lexington Clipper-Herald· 7 days agoArtificial intelligence voice-cloning technology carries many risks. But a team of doctors and their...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Morningstar· 3 days agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDTCAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on ...